Gentian Diagnostics AS serves the global market with sensitive diagnostic tests. Current and pipeline products contribute to improved diagnostics and cost reductions in treatment of kidneys, inflammation, cardiovascular diseases, cancer and viral infections.
On 14th December, 2016, Gentian Diagnostics AS was admitted to the Oslo Stock Exchange under GENT.
Find more information about the Gentian Share on Oslo Børs.
Learn more about Gentian Diagnostics AS here.
Financial Calendar 2021
11TH FEB - QUARTERLY REPORT- Q4
16TH APR - ANNUAL REPORT
- 16th April 2021 - Annual Report
16TH APR - QUARTERLY REPORT - Q1
- 16th April 2021 - Quarterly Report - Q1
- 16th April 2021 - Quarterly Presentation - Q1
4TH MAY - ANNUAL GENERAL MEETING
- 4th May 2021 - AGM Minutes GD AS
25TH AUG - HALF-YEARLY REPORT
- 25th August 2021 - Half-Yearly Report
- 25th August 2021 - Half-Yearly Presentation
21ST OCT - QUARTERLY REPORT - Q3
- 21st October 2021 - Quarterly Report - Q3
- 21st October 2021 - Quarterly Presentation - Q3
Financial Calendar 2020
14TH FEB - QUARTERLY REPORT- Q4
24TH APR - ANNUAL REPORT
24TH APR - QUARTERLY REPORT - Q1
14TH MAY - ANNUAL GENERAL MEETING
21ST AUG - HALF-YEARLY REPORT
29TH OCT - QUARTERLY REPORT - Q3
14th of May 2020: Annual General Meeting
The 2020 Annual General Meeting of Gentian Diagnostics AS will be held on 14 May 2020 at 10:00 (CEST) at Bjørnåsveien 5, 1596 Moss.
Please find the notice incl. appendices enclosed here:
- 14th May 2020 - AGM Minutes GD AS
- Notice of Annual General Meeting for Gentian Diagnostics AS 14.05.2020
- 2019 Annual Report Gentian Diagnostics AS
- 2020 Proposal from Nomination Committee